Immunovant
Sarah York currently serves as the Director of Regulatory Affairs at Immunovant, a position held since January 2022, after previously being the Associate Director of Regulatory Affairs at the same company. With extensive experience in regulatory affairs, positions include Regulatory Affairs Manager at Morphic Therapeutic and at Corbus Pharmaceuticals, as well as roles at Ironwood Pharmaceuticals and Momenta Pharmaceuticals. Prior to a career in regulatory affairs, Sarah worked in various capacities in the legal field, including as a Paralegal at Kaplan & Nichols, P.C. and WilmerHale. Educational credentials include a Master's Degree in Regulatory Affairs for Drugs, Biologics and Medical Devices from Northeastern University and a Bachelor of Arts in History from Boston University.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.